These combinations increase the risk of hypoglycemia, especially during a transition period
Frail patients start with the most dysfunction, so they have the most to gain. In fact, after one year, patients on semaglutide demonstrated an 11-point improvement on the Kansas City Cardiomyopathy QuestionnaireClinical Summary Score, which represented a shift into a less-frail stratum for many
It is here to help you deal with these side effects while still getting the most out of your treatment for blood sugar and weight loss
10.1016/j.clinthera.2005.02.008 14 CarlssonL
Guan et al., 1997
SUSTAIN-6, conducted in patients with type 2 diabetes, showed a 26% reduction in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) with semaglutide compared to placebo